Applications and Challenges of Photodynamic Therapy in the Treatment of Skin Malignancies

Overview

Journal Front Pharmacol

Date 2024 Oct 4

PMID 39364058

Authors

Yunqi Hua

Xiaoling Tian

Xinyi Zhang

Ge Song

Yubo Liu

Ye Zhao

Yuqian Gao

Fangrui Yin

Affiliations

Soon will be listed here.

Abstract

Photodynamic Therapy (PDT), as a minimally invasive treatment method, has demonstrated its distinct advantages in the management of skin malignant tumors. This article examines the current application status of PDT, assesses its successful cases and challenges in clinical treatment, and anticipates its future development trends. PDT utilizes photosensitizers to interact with light of specific wavelengths to generate reactive oxygen species that selectively eradicate cancer cells. Despite PDT's exceptional performance in enhancing patients' quality of life and prognosis, the limitation of treatment depth and the side effects of photosensitizers remain unresolved issues. With the advancement of novel photosensitizers and innovative treatment technology, the application prospects of PDT are increasingly expansive. This article delves into the mechanism of PDT, its application in various skin malignancies, its advantages and limitations, and envisions its future development. We believe that through continuous technological enhancements and integration with other treatment technologies, PDT has the potential to assume a more pivotal role in the treatment of skin malignancies.

Citing Articles

Photodynamic Therapy in Cancer: Insights into Cellular and Molecular Pathways.

Papa V, Furci F, Minciullo P, Casciaro M, Allegra A, Gangemi S Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996790 PMC: 11854756. DOI: 10.3390/cimb47020069.

References

Itoo A, Vemula S, Gupta M, Giram M, Kumar S, Ghosh B . Multifunctional graphene oxide nanoparticles for drug delivery in cancer. J Control Release. 2022; 350:26-59. DOI: 10.1016/j.jconrel.2022.08.011. View

Magnussen A, Reburn C, Perry A, Wood M, Curnow A . Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy. Lasers Med Sci. 2021; 37(2):1155-1166. PMC: 8918167. DOI: 10.1007/s10103-021-03367-1. View

Zhan Q, Wu C, Ding H, Huang Y, Jiang Z, Liao N . Emerging trends in photodynamic therapy for head and neck cancer: A 10-year bibliometric analysis based on CiteSpace. Photodiagnosis Photodyn Ther. 2022; 38:102860. DOI: 10.1016/j.pdpdt.2022.102860. View

Lou L, Zhou S, Tan S, Xiang M, Wang W, Yuan C . Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology. Front Pharmacol. 2023; 14:1137707. PMC: 10008889. DOI: 10.3389/fphar.2023.1137707. View

Varzandeh M, Mohammadinejad R, Esmaeilzadeh-Salestani K, Dehshahri A, Zarrabi A, Aghaei-Afshar A . Photodynamic therapy for leishmaniasis: Recent advances and future trends. Photodiagnosis Photodyn Ther. 2021; 36:102609. DOI: 10.1016/j.pdpdt.2021.102609. View

Nowak-Perlak M, Ziolkowski P, Wozniak M . A promising natural anthraquinones mediated by photodynamic therapy for anti-cancer therapy. Phytomedicine. 2023; 119:155035. DOI: 10.1016/j.phymed.2023.155035. View

Volety P, Shirley C, Chhabra G, Ahmad N . The fusion of light and immunity: Advancements in photoimmunotherapy for melanoma. Photochem Photobiol. 2024; 100(4):910-922. PMC: 11286352. DOI: 10.1111/php.13951. View

Jones O, Ranmuthu C, Hall P, Funston G, Walter F . Recognising Skin Cancer in Primary Care. Adv Ther. 2019; 37(1):603-616. PMC: 6969010. DOI: 10.1007/s12325-019-01130-1. View

Li L, Wang Z, Guo H, Lin Q . Nanomaterials: a promising multimodal theranostics platform for thyroid cancer. J Mater Chem B. 2023; 11(32):7544-7566. DOI: 10.1039/d3tb01175e. View

10.

Sharma K, Bowers N, Davids L . Photodynamic therapy-induced killing is enhanced in depigmented metastatic melanoma cells. Cell Biol Int. 2011; 35(9):939-44. DOI: 10.1042/CBI20110103. View

11.

Kessel D . Photodynamic Therapy: Critical PDT Theory. Photochem Photobiol. 2022; 99(2):199-203. DOI: 10.1111/php.13616. View

12.

Zeng Q, Zhou C, Zhang Y, Yan G, Wang X . Modified 5-aminolevulinic acid photodynamic therapy reduces pain and improves therapeutic effects in cutaneous squamous cell carcinoma mouse model. Lasers Surg Med. 2022; 54(5):804-812. DOI: 10.1002/lsm.23516. View

13.

Kah G, Chandran R, Abrahamse H . Curcumin a Natural Phenol and Its Therapeutic Role in Cancer and Photodynamic Therapy: A Review. Pharmaceutics. 2023; 15(2). PMC: 9962422. DOI: 10.3390/pharmaceutics15020639. View

14.

Li X, Vinothini K, Ramesh T, Rajan M, Ramu A . Combined photodynamic-chemotherapy investigation of cancer cells using carbon quantum dot-based drug carrier system. Drug Deliv. 2020; 27(1):791-804. PMC: 7301704. DOI: 10.1080/10717544.2020.1765431. View

15.

Liao C, Zhang G, Wang P, Sun X, Wang X . Combination curettage and modified ALA-PDT for multiple basal cell carcinomas of the face and head. Photodiagnosis Photodyn Ther. 2021; 35:102393. DOI: 10.1016/j.pdpdt.2021.102393. View

16.

Zeng Q, Liu J, Yan Y, Zhang G, Wang P, Zhang H . Modified 5-aminolevulinic acid photodynamic therapy suppresses cutaneous squamous cell carcinoma through blocking Akt/mTOR-mediated autophagic flux. Front Pharmacol. 2023; 14:1114678. PMC: 10063783. DOI: 10.3389/fphar.2023.1114678. View

17.

Espineira Sicre J, Garcia Sirvent L, Ruiz Sanchez J, Garcia Fernandez L, Soro Martinez P, Miralles Botella J . Neoadjuvant photodynamic therapy as a therapeutic alternative in multiple basal cell carcinoma induced by radiotherapy. Photodiagnosis Photodyn Ther. 2023; 44:103820. DOI: 10.1016/j.pdpdt.2023.103820. View

18.

Xu X, Chen S, Yi N, Li X, Chen S, Lei Z . Research progress on tumor hypoxia-associative nanomedicine. J Control Release. 2022; 350:829-840. DOI: 10.1016/j.jconrel.2022.09.003. View

19.

Yan J, Wang B, Zhang G, Liao C, Zhao Z, Wang P . Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers. Curr Treat Options Oncol. 2024; 25(6):813-826. DOI: 10.1007/s11864-024-01209-0. View

20.

Chen H, Hou K, Yu J, Wang L, Chen X . Nanoparticle-Based Combination Therapy for Melanoma. Front Oncol. 2022; 12:928797. PMC: 9273962. DOI: 10.3389/fonc.2022.928797. View